Status:
UNKNOWN
Investigation of an Abdominal Compression Device
Lead Sponsor:
The Clatterbridge Cancer Centre NHS Foundation Trust
Conditions:
Cancer, Lung
Cancer of Stomach
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study is applicable to patients undergoing lower lung or abdomen stereotactic ablative body radiotherapy (SABR) treatment. The purpose of the ACE 01 study is to identify if, the volume of healthy...
Detailed Description
Stereotactic ablative body radiotherapy (SABR) offers the ability to deliver a high dose of radiotherapy accurately to small tumours. It is an established, effective, non-invasive treatment option for...
Eligibility Criteria
Inclusion
- • Radiological or Histologically confirmed lower lobe lung cancer or histologically confirmed metastatic of primary cancer in abdominal organs including liver, pancreas, adrenal which meets criteria for SABR treatment.
- Aged 18 years or over
- Capacity to understand research proposal and give informed consent
Exclusion
- Tumour sites excluding those previously defined
- Rib metastases
- Stoma if situated underneath belt
- Patients unable to tolerate the abdominal compression belt
- Patients with existing abdominal aortic aneurysm (AAA)
Key Trial Info
Start Date :
June 21 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 30 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04270890
Start Date
June 21 2018
End Date
April 30 2022
Last Update
January 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clatterbridge Cancer Centre NHS Foundation Trust
Bebington, United Kingdom, CH634JY